Nothing Special   »   [go: up one dir, main page]

Andersson, 1981 - Google Patents

Purification and studies of components of the haemostatic system by affinity chromatography

Andersson, 1981

Document ID
12323892867145886967
Author
Andersson L
Publication year
Publication venue
Journal of Chromatography A

External Links

Snippet

The application of affinity chromatographic techniques for separations and studies on molecular interactions of the components of the blood coagulation system is reviewed. Most of the components have been purified using processes involving one or several affinity …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Similar Documents

Publication Publication Date Title
Suzuki et al. Protein C inhibitor. Purification from human plasma and characterization.
Kisiel et al. [26] Protein C
Broze et al. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action
Østerud et al. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X
Marlar et al. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme
Suenson et al. Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator
Fuchs et al. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
US5580962A (en) Parenterally administrable drug having thrombolytic activity and containing protein C
Booth et al. Plasminogen activator inhibitor from human endothelial cells: purification and partial characterization
Rao et al. Activation of human factor VII during clotting in vitro
Malinconico et al. Hementin: anticoagulant protease from the salivary gland of the leech Haementeria ghilianii
Sakata et al. Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency
Haley et al. The activation of bovine protein C by factor Xa
EP0907724B1 (en) Von willebrand factor multimerase
Walker et al. The effects of phospholipid and factor Va on the inhibition of factor Xa by antithrombin III
AU743102B2 (en) Pharmaceutical substance containing various vitamin K-dependent factors
Pratt et al. Protein C inhibitor: purification and proteinase reactivity
US6034222A (en) Method for the separation of recombinant pro-factor IX from recombinant factor IX
Modi et al. The isolation of prothrombin, factor IX and factor X from human factor IX concentrates
España et al. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents
Feldman et al. Large-scale preparation and biochemical characterization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography
Nilsson Coagulation and fibrinolysis
Almenoff et al. Identification of a thermolysin-like metalloendopeptidase in serum: activity in normal subjects and in patients with sarcoidosis
Kisiel et al. Isolation of a protein C activator from southern copperhead venom
Costa et al. Partial characterization of an autoantibody recognizing the secondary binding site (s) of thrombin in a patient with recurrent spontaneous arterial thrombosis